Navigation Links


Monogenic in Medical News

Sangamo BioSciences Presents Positive Phase 2 ZFP Therapeutic Data at ADA 2009

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its ZFP Technology, including Dow ...

Sangamo BioSciences Announces Presentation at the JMP Securities Research Conference

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Reports First Quarter 2009 Financial Results

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

New stem cell technique improves genetic alteration

... could use the technique to correct the disorder in stem cells, then use the healthy cells in a treatment. The method potentially could help treat monogenic diseases, which result from modifications in a single gene occurring in all cells of the body. Though relatively rare, these diseases affect millions ...

Genetic susceptibility in viral encephalitis

... a substantial risk. "In contrast to most current thinking, we suspected that herpes simplex encephalitis susceptibility could be inherited as a monogenic trait resulting in the specific impairment of immunity to herpes simplex virus-1," Beutler said. "Here we have defined a genetic lesion that is ...
Monogenic in Medical Technology

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its ZFP Technology, including Dow ...

Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives

... and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)

... and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting

... development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines

... development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results

... development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy

... programs are focused on Amyotrophic Lateral Sclerosis (ALS), cancer and HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...
Monogenic in Medical Definition

Medicine

... Drug ampoules Genomics and knowledge of human genetics is already having some influence on medicine, as the causative genes of most monogenic genetic disorders have now been identified, and the development of techniques in molecular biology and genetics are influencing medical practice ...
Monogenic in Biological News

A new analysis method allows to find out the sex of the baby from the second month of pregnancy

... send it to Lorgen and receive the results 48 hours later. Diagnosis of monogenic diseases This new process, apart from saving the parents the wait until ... with important medical applications; especially in the diagnosis of monogenic diseases related to X chromosome, such as haemophilia or Duchenne muscular ...

Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference

... development programs are focused on stem cell mobilization, ALS, cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

The importance of gene regulation for common human disease

... our analysis will help to develop that understanding, a vital step on the path from genetics to improvements in healthcare." Past studies of rare, monogenic disease, such as cystic fibrosis and sickle-cell anaemia, have focused on changes to the protein-coding regions of genes because they have been ...
Monogenic in Biological Technology

Sangamo BioSciences Reports Second Quarter 2009 Financial Results

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its ZFP technology, including Dow ...

Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo has established strategic partnerships with companies in non-therapeutic applications of its ZFP Technology, including Dow ...

Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). By ...

Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results

... treatment of HIV/AIDS. Other therapeutic development programs are focused on cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS

... and ALS. Other therapeutic development programs are focused on HIV/AIDS, cancer, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast

... and ALS. Other therapeutic development programs are focused on cancer, HIV/AIDS, neuropathic pain, nerve regeneration, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...

Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement

... and ALS. Other therapeutic development programs are focused on stem cell mobilization, HIV/AIDS, cancer, neuropathic pain, Parkinson's disease and monogenic diseases. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs). ...
Monogenic in Biological Dictionary

Monogenic

... monogenic . From Wikipedia, the free encyclopedia. Jump ... from "http://en.wikipedia.org /wiki/ monogenic " Categories: Disambiguation pages ... ... over the past few months is remarkable. ... monogenic forms of diabetes may account for about 1 to 2 ...

Single-gene disorder

... Defects - From the The Merck Manual of Diagnosis and Therapy. ... See hereditary hemochromatosis disorder and gene profiles for more ... monogenic disorder . A disorder caused by mutation of a single gene . ... See also: single - gene disorder . Polymerase chain reaction (PCR) ... ....

Megabase cloning

... lactone Mapping Megabase cloning Meiosis Messenger RNA (mRNA) ... Molecular cloning . Molecular genetics. Monoclonal antibodies. Monoculture. monogenic ... Megabase cloning . Meiosis. Messenger RNA (mRNA). Metabolism. Metallothionein. Microbe ... Molecular cloning . Molecular genetics. ...
Other Contentspersistencepersistencepersistencepetiolepetalphagocytephagocytephagemidphagemidphagocytesphagocytesphagocytesphagocytosisphagocytosisphagocytosispharynxpharynxpharynx
(Date:11/27/2009)... 27 The Gymboree Corpora..., CFO/COO, will present at the NASDAQ OMX 23rd Inv...Hotel in London, England, on Wednesday, December 2...ve broadcast of The Gymboree Corporation,s present...oree.com, click on "Our Company" at the bottom of ...
(Date:11/27/2009)...ael, Nov. 27 Shamir Opti... leading provider of innovative products and techn...ay that its board of directors had declared a divi... million (approximately NIS 37.62 million based on...ange), or approximately US$ 0.609 (approximately N...
(Date:11/27/2009)...dented medical, economic burdens, study predicts ,...he number of people with diabetes in the United St... a new study predicts. , That would bring the t... disease, up from 23.7 million today. , , At the...tes will triple, the study also warns, rising from...
(Date:11/27/2009)...i-purpose bilingual coloring books designed for ch...ess community to educate - inform parents and chil...sues to Dinosuars to ABC,S and a host of other top...RWEB) November 27, 2009 -- Today’s children ...hem busy any hour of the day, but one of the oldes...
(Date:11/26/2009)... With cold and flu season upon us, ...ices to control the spread of infections and avoid...to keep ourselves healthy, but to avoid transmitti..., MS, CIC (certified in infection-control), nursin...health at Hospital for Special Surgery (HSS) in Ma...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4
(Date:11/23/2009)...Farmington, CT Current research suggests that a c...ease. The related report by Nichols et al, "Uniqu... New Class of TLR2 Ligands Capable of Enhancing Au... The American Journal of Pathology . , Multiple... attacks the brain and spinal cord, affects nearly...
(Date:11/23/2009)..., AMES, Iowa - The only swine vaccine available fo...e herd infected with the virus. The vaccination ma...e herd diagnosed with the pandemic flu., Iowa St...science, developed the vaccine this summer and has... in Iowa, Kansas and Illinois for several weeks.,...
(Date:11/23/2009)...MADISON, WI, November 16, 2009 -- A USDOE and USDA...pland, idle cropland, and cropland pasture could b... perennial grasses, such as switchgrass, from whic...feedstock. Economically viable production of a per...antities of biomass are removed annually is expect...
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2Breast Cancer Art Shares Journeys of Hope Reconstruction 60018 1Breast Cancer Art Shares Journeys of Hope Reconstruction 60018 2Pennsylvania Department of Health Continues Statewide Distribution H1N1 Vaccine 60014 1Pennsylvania Department of Health Continues Statewide Distribution H1N1 Vaccine 60014 2FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients Settings 60010 1FDA Authorizes Emergency Use of Intravenous Antiviral Peramivir for 2009 H1N1 Influenza for Certain Patients Settings 60010 2
Other TagsThrombinOther Tagsclimatic 2carried 2carried 3carried 4carried 5carried 6carried 7carried 8carried 9carried 10